Loading...
BEVIDES B logo

Farmacias Benavides, S.A.B. de C.V.BMV:BEVIDES B Stock Report

Market Cap Mex$10.6b
Share Price
Mex$26.00
Mex$87.58
70.3% undervalued intrinsic discount
1Y4.0%
7D2.2%
1D
Portfolio Value
View

Farmacias Benavides, S.A.B. de C.V.

BMV:BEVIDES B Stock Report

Market Cap: Mex$10.6b

Farmacias Benavides. de (BEVIDES B) Stock Overview

Engages in the retail of health and wellness products. More details

BEVIDES B fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance6/6
Financial Health5/6
Dividends0/6

BEVIDES B Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Farmacias Benavides, S.A.B. de C.V. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Farmacias Benavides. de
Historical stock prices
Current Share PriceMex$26.00
52 Week HighMex$26.00
52 Week LowMex$25.00
Beta0.12
1 Month Changen/a
3 Month Changen/a
1 Year Change4.00%
3 Year Changen/a
5 Year Change85.71%
Change since IPO365.95%

Recent News & Updates

Recent updates

Analysis Article Dec 18

Farmacias Benavides. de (BMV:BEVIDESB) Seems To Use Debt Quite Sensibly

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article Nov 20

Farmacias Benavides, S.A.B. de C.V.'s (BMV:BEVIDESB) Shares May Have Run Too Fast Too Soon

When close to half the companies in Mexico have price-to-earnings ratios (or "P/E's") below 11x, you may consider...
Analysis Article Aug 23

There May Be Some Bright Spots In Farmacias Benavides. de's (BMV:BEVIDESB) Earnings

The market for Farmacias Benavides, S.A.B. de C.V.'s ( BMV:BEVIDESB ) shares didn't move much after it posted weak...
Analysis Article Jul 01

Shareholders Would Enjoy A Repeat Of Farmacias Benavides. de's (BMV:BEVIDESB) Recent Growth In Returns

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...
Analysis Article May 16

Farmacias Benavides. de's (BMV:BEVIDESB) Robust Earnings Are Supported By Other Strong Factors

Even though Farmacias Benavides, S.A.B. de C.V.'s ( BMV:BEVIDESB ) recent earnings release was robust, the market...
Analysis Article May 04

The Trend Of High Returns At Farmacias Benavides. de (BMV:BEVIDESB) Has Us Very Interested

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...

Shareholder Returns

BEVIDES BMX Consumer RetailingMX Market
7D2.2%-1.6%-3.8%
1Y4.0%-20.6%12.8%

Return vs Industry: BEVIDES B exceeded the MX Consumer Retailing industry which returned -20% over the past year.

Return vs Market: BEVIDES B underperformed the MX Market which returned 12.9% over the past year.

Price Volatility

Is BEVIDES B's price volatile compared to industry and market?
BEVIDES B volatility
BEVIDES B Average Weekly Movementn/a
Consumer Retailing Industry Average Movement3.3%
Market Average Movement4.0%
10% most volatile stocks in MX Market6.2%
10% least volatile stocks in MX Market2.6%

Stable Share Price: BEVIDES B's share price has been volatile over the past 3 months compared to the MX market.

Volatility Over Time: Insufficient data to determine BEVIDES B's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19178,023Mauricio Gutiérrez-Lascuráinwww.benavides.com.mx

Farmacias Benavides, S.A.B. de C.V. engages in the retail of health and wellness products. The company also provides medicamentos, non-perishable food, and hygiene and beauty products, as well as photography. The company was founded in 1917 and is based in Monterrey, Mexico.

Farmacias Benavides, S.A.B. de C.V. Fundamentals Summary

How do Farmacias Benavides. de's earnings and revenue compare to its market cap?
BEVIDES B fundamental statistics
Market capMex$10.63b
Earnings (TTM)Mex$455.21m
Revenue (TTM)Mex$20.73b
23.4x
P/E Ratio
0.5x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BEVIDES B income statement (TTM)
RevenueMex$20.73b
Cost of RevenueMex$14.66b
Gross ProfitMex$6.07b
Other ExpensesMex$5.62b
EarningsMex$455.21m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)1.11
Gross Margin29.29%
Net Profit Margin2.20%
Debt/Equity Ratio0%

How did BEVIDES B perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/08 18:02
End of Day Share Price 2026/06/02 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Farmacias Benavides, S.A.B. de C.V. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.